Hvivo PLC (LON:HVO) insider James Winschel purchased 2,221 shares of the firm’s stock in a transaction on Tuesday, October 11th. The stock was bought at an average cost of GBX 180 ($2.23) per share, with a total value of £3,997.80 ($4,947.77).

Hvivo PLC (LON:HVO) opened at 171.4375 on Wednesday. The firm’s market capitalization is GBX 133.83 million. Hvivo PLC has a one year low of GBX 167.00 and a one year high of GBX 282.50. The firm has a 50-day moving average price of GBX 178.92 and a 200-day moving average price of GBX 186.41.

Separately, Numis Securities Ltd reissued an “add” rating and issued a GBX 210 ($2.60) price target on shares of Hvivo PLC in a report on Thursday, September 22nd.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/12/insider-buying-hvivo-plc-hvo-insider-purchases-2221-shares-of-stock.html

About Hvivo PLC

hVIVO plc, formerly Retroscreen Virology Group plc, is a holding company. The Company is engaged in a life sciences business pioneering a technology platform of human disease models to accelerate drug discovery and development in respiratory and infectious diseases, including flu, respiratory syncytial virus (RSV), asthma and common cold.

Receive News & Ratings for Hvivo PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hvivo PLC and related companies with MarketBeat.com's FREE daily email newsletter.